# OnCo record paper-labrousse-enspyre-sci-rep-2026 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-labrousse-enspyre-sci-rep-2026/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-labrousse-enspyre-sci-rep-2026" ;
  schema:name "Enrichment of mutated DNA enables ultra-sensitive ctDNA detection in NSCLC using shallow targeted sequencing"@en ;
  schema:description "A chemistry that enriches the tumour's mutated DNA before sequencing found lung cancer DNA at a few parts per million with far less sequencing than usual."@en ;
  schema:url <https://onco.cc/key-papers/paper-labrousse-enspyre-sci-rep-2026/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/s41598-026-57421-5>, <https://pubmed.ncbi.nlm.nih.gov/42288656/> ;
  schema:sameAs <https://doi.org/10.1038/s41598-026-57421-5> ;
  schema:datePublished "2026"^^xsd:gYear ;
  schema:author "Labrousse P, Russell H, Stetson D, et al." ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:sections <https://onco.cc/fronts/diagnostics/> ;
  onco:technologies <https://onco.cc/technologies/mrd-testing/> ;
  onco:drugs <https://onco.cc/drugs/enspyre-mrd/> ;
  onco:companies <https://onco.cc/companies/biofidelity/> ;
  onco:terms <https://onco.cc/terms/mrd/>, <https://onco.cc/terms/ctdna/>, <https://onco.cc/terms/tumour-informed-assay/> .